These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 32212533)

  • 1. A Modified Vaccine against Smallpox.
    Engler R; Cooper LT
    N Engl J Med; 2020 Mar; 382(13):1285. PubMed ID: 32212533
    [No Abstract]   [Full Text] [Related]  

  • 2. Modified vaccinia Ankara: potential as an alternative smallpox vaccine.
    McCurdy LH; Larkin BD; Martin JE; Graham BS
    Clin Infect Dis; 2004 Jun; 38(12):1749-53. PubMed ID: 15227622
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical development of Modified Vaccinia virus Ankara vaccines.
    Gilbert SC
    Vaccine; 2013 Sep; 31(39):4241-6. PubMed ID: 23523410
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of modified vaccinia virus Ankara as an alternative vaccine against smallpox in chronically HIV type 1-infected individuals undergoing HAART.
    Cosma A; Nagaraj R; Staib C; Diemer C; Wopfner F; Schätzl H; Busch DH; Sutter G; Goebel FD; Erfle V
    AIDS Res Hum Retroviruses; 2007 Jun; 23(6):782-93. PubMed ID: 17604541
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phase 3 Efficacy Trial of Modified Vaccinia Ankara as a Vaccine against Smallpox.
    Pittman PR; Hahn M; Lee HS; Koca C; Samy N; Schmidt D; Hornung J; Weidenthaler H; Heery CR; Meyer TPH; Silbernagl G; Maclennan J; Chaplin P
    N Engl J Med; 2019 Nov; 381(20):1897-1908. PubMed ID: 31722150
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Study of the virus of anti-smallpox vaccine cultured in tissues. Its use in the preparation of a vaccine].
    CAMPILLO C
    Gac Med Mex; 1959 May; 89():437-49. PubMed ID: 13807316
    [No Abstract]   [Full Text] [Related]  

  • 7. Enhanced immunogenicity and protective effect conferred by vaccination with combinations of modified vaccinia virus Ankara and licensed smallpox vaccine Dryvax in a mouse model.
    Meseda CA; Garcia AD; Kumar A; Mayer AE; Manischewitz J; King LR; Golding H; Merchlinsky M; Weir JP
    Virology; 2005 Sep; 339(2):164-75. PubMed ID: 15993917
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of a highly efficacious vaccinia-based dual vaccine against smallpox and anthrax, two important bioterror entities.
    Merkel TJ; Perera PY; Kelly VK; Verma A; Llewellyn ZN; Waldmann TA; Mosca JD; Perera LP
    Proc Natl Acad Sci U S A; 2010 Oct; 107(42):18091-6. PubMed ID: 20921397
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New generation smallpox vaccines: a review of preclinical and clinical data.
    Artenstein AW
    Rev Med Virol; 2008; 18(4):217-31. PubMed ID: 18283712
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Third-generation smallpox vaccine strain-based recombinant vaccines for viral hemorrhagic fevers.
    Yoshikawa T
    Vaccine; 2021 Oct; 39(41):6174-6181. PubMed ID: 34521550
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mouse neurotoxicity test for vaccinia-based smallpox vaccines.
    Li Z; Rubin SA; Taffs RE; Merchlinsky M; Ye Z; Carbone KM
    Vaccine; 2004 Mar; 22(11-12):1486-93. PubMed ID: 15063573
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of variola and vaccinia virus neutralization assays for smallpox vaccines.
    Hughes CM; Newman FK; Davidson WB; Olson VA; Smith SK; Holman RC; Yan L; Frey SE; Belshe RB; Karem KL; Damon IK
    Clin Vaccine Immunol; 2012 Jul; 19(7):1116-8. PubMed ID: 22593237
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Humoral Immunity to Primary Smallpox Vaccination: Impact of Childhood versus Adult Immunization on Vaccinia Vector Vaccine Development in Military Populations.
    Slike BM; Creegan M; Marovich M; Ngauy V
    PLoS One; 2017; 12(1):e0169247. PubMed ID: 28046039
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of a vaccinia virus strain used to produce smallpox vaccine in Argentina between 1937 and 1970.
    Lewis A; Bok K; Perez O; DeFillippo J; Paolazzi C; Gomez JA
    Arch Virol; 2005 Jul; 150(7):1485-91. PubMed ID: 15750861
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Smallpox vaccines for biodefense: need and feasibility.
    Artenstein AW; Grabenstein JD
    Expert Rev Vaccines; 2008 Oct; 7(8):1225-37. PubMed ID: 18844596
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety, immunogenicity, and surrogate markers of clinical efficacy for modified vaccinia Ankara as a smallpox vaccine in HIV-infected subjects.
    Greenberg RN; Overton ET; Haas DW; Frank I; Goldman M; von Krempelhuber A; Virgin G; Bädeker N; Vollmar J; Chaplin P
    J Infect Dis; 2013 Mar; 207(5):749-58. PubMed ID: 23225902
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risks and benefits of vaccinia vaccine use in the worldwide smallpox eradication campaign.
    Fenner F
    Res Virol; 1989; 140(5):465-6; discussion 487-91. PubMed ID: 2685955
    [No Abstract]   [Full Text] [Related]  

  • 18. Determination of immunity to vaccinia virus by using diluted inactivated vaccinia vaccine solution for skin testing.
    Somekh E; Smetana Z; Tanay A; Dalal I; Babai I; Mendelson E
    Vaccine; 2004 Dec; 23(3):321-4. PubMed ID: 15530675
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vaccination of BALB/c mice with Escherichia coli-expressed vaccinia virus proteins A27L, B5R, and D8L protects mice from lethal vaccinia virus challenge.
    Berhanu A; Wilson RL; Kirkwood-Watts DL; King DS; Warren TK; Lund SA; Brown LL; Krupkin AK; Vandermay E; Weimers W; Honeychurch KM; Grosenbach DW; Jones KF; Hruby DE
    J Virol; 2008 Apr; 82(7):3517-29. PubMed ID: 18199639
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A mouse-based assay for the pre-clinical neurovirulence assessment of vaccinia virus-based smallpox vaccines.
    Zhang CX; Sauder C; Malik T; Rubin SA
    Biologicals; 2010 Mar; 38(2):278-83. PubMed ID: 19896867
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.